Ochre Bio
Pre-clinicalOchre Bio is developing therapies for the biggest liver health challenges.
Founded
2019
Focus
RNA & Gene Therapy
About
Ochre Bio is developing therapies for the biggest liver health challenges.
Funding History
2Total raised: $33.2M
Series A$30MKhosla VenturesOct 15, 2022
Seed$3.2MBacked VCSep 15, 2020
Company Info
TypePrivate
Founded2019
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile